Stress-induced hypertensive reaction in a patient receiving monoamine oxidase inhibitors: Report of a case

Journal of Oral and Maxillofacial Surgery

Volumn 44, Issue 10, 1986, Pages 830-832

  Kloberdanz, Brian ^a   Vaughn, Robert L ^a   Bennett, C Richard ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHLORPROMAZINE; FLURAZEPAM; MEPIVACAINE; MONOAMINE OXIDASE INHIBITOR; NITROUS OXIDE; OXYGEN; TRANYLCYPROMINE;

ADVERSE DRUG REACTION; CARDIOVASCULAR SYSTEM; CASE REPORT; CENTRAL NERVOUS SYSTEM; DEPRESSION; DRUG THERAPY; HUMAN; HYPERTENSION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; STRESS; THERAPY;

ADULT; CASE REPORT; FEMALE; FLURAZEPAM; HEADACHE; HUMAN; HYPERTENSION; STRESS; STRESS, PSYCHOLOGICAL; TRANYLCYPROMINE;

EID: 0022495219     PISSN: 02782391     EISSN: None     Source Type: Journal    
DOI: 10.1016/0278-2391(86)90166-7     Document Type: Article

References (26)

1. Towards rational therapy with monoamine oxidase inhibitors
2. New studies confirm MAO-I efficacy in treatment of severe anxiety (editorial)
3. Monoamine oxidase inhibitors: prescription and patient management
4. Series in pharmacology in practice. Drugs that alter mood. Tricyclic agents and MAO-I
5. Adverse effects of antidepressant drugs. Part I. MAO-I and tricyclics
6. Mode of action of antidepressant drugs
7. Potentiation of pethidine
8. Potentiation of meperidine hydrochloride by pargyline hydrochloride
9. Effect of monoamine oxidase inhibitors on the N-demethylation and hydrolysis of meperidine
10. Beware—the use of MAO-I is increasing again
11. Inhibition of serotonin uptake and the toxic interaction between meperidine and MAO-I
12. A study of the tranylcypramine-meperidine interaction: effects of p-chlorophenylalanine and 1-5-hydroxytryptophan
13. Hypertensive interactions between monoamine oxidase inhibitors and food-stuffs
14. Adverse reactions to monoamine oxidase inhibitors. Part II. Treatment correlates and clinical management
15. Monoamine oxidase inhibitors: should they be discontinued preoperatively?
16. The use of pethidine and morphine in the presence of monoamine oxidase inhibitors
17. Modification by monoamine oxidase inhibitors of the effect of some sympathomimetics on blood pressure
18. Monoamine oxidase inhibitors, adverse reactions and possible mechanisms
19. Interactions between sympathomimetic amines and antidepressant agents in man
20. Cardiac toxicity of Iproniazid (Marsilid) Report of myocardial injury in a patient receiving levarterenol
21. Subarachnoid hemorrhage following ephedrine and MAO-I
22. Cough and cold remedies. A potential danger to patients on monoamine oxidase inhibitors
23. Hypertensive crisis resulting from MAO-I and an over-the-counter appetite suppressant